Fri Sep 20 06:08:04 UTC 2024: ## Olympus Launches 4K Endoscopic Camera Head for Urology and Gynecology Procedures

**TOKYO, Sept 20, 2024** – Olympus Corporation, a global MedTech leader, announced the launch of a new 4K camera head, the CH-S700-08-LB, designed for endoscopic procedures in urology and gynecology in Europe. This innovative camera head, developed in collaboration with Sony, is compatible with the VISERA ELITE III video system center for surgical endoscopy.

The new camera head boasts four times the pixel count of conventional HD camera heads, delivering exceptional image clarity in both 4K white light and 4K Narrow Band Imaging (NBI). It also includes a Blue Light (BL) observation function, offering versatile imaging capabilities within a single device. This comprehensive approach allows surgeons to address a wider range of clinical needs.

The enhanced image quality promises to significantly improve diagnosis and treatment of urological diseases, particularly bladder cancer. The camera head is expected to contribute to earlier detection, minimally invasive treatment, and better follow-up care for non-muscle invasive bladder cancer (NMIBC).

Olympus emphasizes its commitment to improving patient outcomes in urology through this latest innovation. The launch of the CH-S700-08-LB, alongside the upcoming VISERA S endoscopic visualization platform for office and ambulatory settings, showcases their dedication to advancing the field and elevating the standard of care.

**Key Features of the CH-S700-08-LB:**

* **True 4K Image Quality and 4K NBI:** Provides exceptional detail and clarity, allowing surgeons to visualize crucial aspects of the mucosa.
* **Unified Visualization:** Enables white light, NBI, and BL observation with a single camera head, eliminating the need for system switches.
* **Effortless Usability and Ergonomics:** Features one-touch autofocus for precise endoscopic visualization.

The CH-S700-08-LB is currently available in Europe and will be launched in Japan, Hong Kong, and Singapore following regulatory approvals.

Read More